Lyka Labs Limited

NSEI:LYKALABS Stock Report

Market Cap: ₹5.3b

Lyka Labs Balance Sheet Health

Financial Health criteria checks 6/6

Lyka Labs has a total shareholder equity of ₹986.9M and total debt of ₹335.0M, which brings its debt-to-equity ratio to 33.9%. Its total assets and total liabilities are ₹1.7B and ₹695.6M respectively. Lyka Labs's EBIT is ₹83.6M making its interest coverage ratio 3.4. It has cash and short-term investments of ₹11.3M.

Key information

33.9%

Debt to equity ratio

₹335.00m

Debt

Interest coverage ratio3.4x
Cash₹11.29m
Equity₹986.86m
Total liabilities₹695.63m
Total assets₹1.68b

Recent financial health updates

We Think Lyka Labs (NSE:LYKALABS) Has A Fair Chunk Of Debt

Nov 21
We Think Lyka Labs (NSE:LYKALABS) Has A Fair Chunk Of Debt

These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Extensively

Jun 08
These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Extensively

Is Lyka Labs (NSE:LYKALABS) A Risky Investment?

Jun 11
Is Lyka Labs (NSE:LYKALABS) A Risky Investment?

These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Reasonably Well

Feb 21
These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Reasonably Well

These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Reasonably Well

Nov 03
These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Reasonably Well

Recent updates

There's Reason For Concern Over Lyka Labs Limited's (NSE:LYKALABS) Massive 36% Price Jump

Aug 22
There's Reason For Concern Over Lyka Labs Limited's (NSE:LYKALABS) Massive 36% Price Jump

Shareholders May Be More Conservative With Lyka Labs Limited's (NSE:LYKALABS) CEO Compensation For Now

Aug 03
Shareholders May Be More Conservative With Lyka Labs Limited's (NSE:LYKALABS) CEO Compensation For Now

Getting In Cheap On Lyka Labs Limited (NSE:LYKALABS) Is Unlikely

Apr 10
Getting In Cheap On Lyka Labs Limited (NSE:LYKALABS) Is Unlikely

Subdued Growth No Barrier To Lyka Labs Limited's (NSE:LYKALABS) Price

Jan 05
Subdued Growth No Barrier To Lyka Labs Limited's (NSE:LYKALABS) Price

We Think Lyka Labs (NSE:LYKALABS) Has A Fair Chunk Of Debt

Nov 21
We Think Lyka Labs (NSE:LYKALABS) Has A Fair Chunk Of Debt

These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Extensively

Jun 08
These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Extensively

A Look At The Fair Value Of Lyka Labs Limited (NSE:LYKALABS)

Mar 15
A Look At The Fair Value Of Lyka Labs Limited (NSE:LYKALABS)

Unpleasant Surprises Could Be In Store For Lyka Labs Limited's (NSE:LYKALABS) Shares

Aug 25
Unpleasant Surprises Could Be In Store For Lyka Labs Limited's (NSE:LYKALABS) Shares

Is Lyka Labs (NSE:LYKALABS) A Risky Investment?

Jun 11
Is Lyka Labs (NSE:LYKALABS) A Risky Investment?

These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Reasonably Well

Feb 21
These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Reasonably Well

Statutory Profit Doesn't Reflect How Good Lyka Labs' (NSE:LYKALABS) Earnings Are

Nov 05
Statutory Profit Doesn't Reflect How Good Lyka Labs' (NSE:LYKALABS) Earnings Are

These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Reasonably Well

Nov 03
These 4 Measures Indicate That Lyka Labs (NSE:LYKALABS) Is Using Debt Reasonably Well

Financial Position Analysis

Short Term Liabilities: LYKALABS's short term assets (₹586.5M) exceed its short term liabilities (₹396.6M).

Long Term Liabilities: LYKALABS's short term assets (₹586.5M) exceed its long term liabilities (₹299.1M).

Debt to Equity History and Analysis

Debt Level: LYKALABS's net debt to equity ratio (32.8%) is considered satisfactory.

Reducing Debt: LYKALABS's debt to equity ratio has reduced from 232.8% to 33.9% over the past 5 years.

Debt Coverage: LYKALABS's debt is well covered by operating cash flow (32.4%).

Interest Coverage: LYKALABS's interest payments on its debt are well covered by EBIT (3.4x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 19:34
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lyka Labs Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution